Cargando…
Fungal Infections in Critically Ill COVID-19 Patients: Inevitabile Malum
Patients with severe COVID-19 belong to a population at high risk of invasive fungal infections (IFIs), with a reported incidence of IFIs in critically ill COVID-19 patients ranging between 5% and 26.7%. Common factors in these patients, such as multiple organ failure, immunomodulating/immunocomprom...
Autores principales: | Rovina, Nikoletta, Koukaki, Evangelia, Romanou, Vasiliki, Ampelioti, Sevasti, Loverdos, Konstantinos, Chantziara, Vasiliki, Koutsoukou, Antonia, Dimopoulos, George |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8999371/ https://www.ncbi.nlm.nih.gov/pubmed/35407625 http://dx.doi.org/10.3390/jcm11072017 |
Ejemplares similares
-
The Real Impact of Age on Mortality in Critically Ill COVID-19 Patients
por: Bakakos, Agamemnon, et al.
Publicado: (2023) -
Dexamethasone in the Treatment of COVID-19: Primus Inter Pares?
por: Romanou, Vasiliki, et al.
Publicado: (2021) -
Fungal Infections in the ICU during the COVID-19 Era: Descriptive and Comparative Analysis of 178 Patients
por: Koukaki, Evangelia, et al.
Publicado: (2022) -
Acid-Base Disturbances in Patients with Asthma: A Literature Review and Comments on Their Pathophysiology
por: Vasileiadis, Ioannis, et al.
Publicado: (2019) -
Modified SCOPE (mSCOPE) Score as a Tool to Predict Mortality in COVID-19 Critically Ill Patients
por: Zanelli, Stavroula, et al.
Publicado: (2023)